30 October 2012 07:39 [Source: ICIS news]
SINGAPORE (ICIS)--Bayer’s net income fell by 17.8% year on year to €528m ($677m) in the third quarter of this year, weighed by special charges relating to legal claims and restructuring expenses, the German major said on Tuesday.
The company’s sales grew by 11.5% year on year to €9.67bn in July-September this year, while earnings before interest and taxes (EBIT) fell by 23.7% to €838m, the company said in a statement.
"We confirm the sales and earnings forecast for 2012 that we raised in July," said Bayer’s management board chairman Marijn Dekkers.
“Bayer continues to anticipate a currency- and portfolio-adjusted sales increase of between 4% and 5% for the full year 2012, which would result in group sales of about €39bn to €40bn,” the company said.
Bayer also plans to increase earnings before interest, tax, depreciation and amortisation (EBITDA) before special items by a “high-single-digit percentage”, the company said.
“In addition to the special charges already recognized, Bayer anticipates further expenses of €200m for ongoing restructuring programs in the fourth quarter of 2012,” it added.
($1 = €0.78)
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
Asian Chemical Connections